190 related articles for article (PubMed ID: 22725730)
1. Identification of a novel, recurrent SLC44A1-PRKCA fusion in papillary glioneuronal tumor.
Bridge JA; Liu XQ; Sumegi J; Nelson M; Reyes C; Bruch LA; Rosenblum M; Puccioni MJ; Bowdino BS; McComb RD
Brain Pathol; 2013 Mar; 23(2):121-8. PubMed ID: 22725730
[TBL] [Abstract][Full Text] [Related]
2. Papillary glioneuronal tumors: histological and molecular characteristics and diagnostic value of SLC44A1-PRKCA fusion.
Pages M; Lacroix L; Tauziede-Espariat A; Castel D; Daudigeos-Dubus E; Ridola V; Gilles S; Fina F; Andreiuolo F; Polivka M; Lechapt-Zalcman E; Puget S; Boddaert N; Liu XQ; Bridge JA; Grill J; Chretien F; Varlet P
Acta Neuropathol Commun; 2015 Dec; 3():85. PubMed ID: 26671581
[TBL] [Abstract][Full Text] [Related]
3. SLC44A1-PRKCA fusion in papillary and rosette-forming glioneuronal tumors.
Nagaishi M; Nobusawa S; Matsumura N; Kono F; Ishiuchi S; Abe T; Ebato M; Wang Y; Hyodo A; Yokoo H; Nakazato Y
J Clin Neurosci; 2016 Jan; 23():73-75. PubMed ID: 26260115
[TBL] [Abstract][Full Text] [Related]
4. Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCA.
Hou Y; Pinheiro J; Sahm F; Reuss DE; Schrimpf D; Stichel D; Casalini B; Koelsche C; Sievers P; Wefers AK; Reinhardt A; Ebrahimi A; Fernández-Klett F; Pusch S; Meier J; Schweizer L; Paulus W; Prinz M; Hartmann C; Plate KH; Reifenberger G; Pietsch T; Varlet P; Pagès M; Schüller U; Scheie D; de Stricker K; Frank S; Hench J; Pollo B; Brandner S; Unterberg A; Pfister SM; Jones DTW; Korshunov A; Wick W; Capper D; Blümcke I; von Deimling A; Bertero L
Acta Neuropathol; 2019 May; 137(5):837-846. PubMed ID: 30759284
[TBL] [Abstract][Full Text] [Related]
5. Papillary Glioneuronal Tumor With a Novel GPR37L1-PRKCA Fusion.
Ahn JS; Ervin J; Cummings TJ; López GY; Wang SJ
J Neuropathol Exp Neurol; 2021 Oct; 80(10):1004-1006. PubMed ID: 34283222
[No Abstract] [Full Text] [Related]
6. EWSR1-PATZ1 gene fusion may define a new glioneuronal tumor entity.
Siegfried A; Rousseau A; Maurage CA; Pericart S; Nicaise Y; Escudie F; Grand D; Delrieu A; Gomez-Brouchet A; Le Guellec S; Franchet C; Boetto S; Vinchon M; Sol JC; Roux FE; Rigau V; Bertozzi AI; Jones DTW; Figarella-Branger D; Uro-Coste E
Brain Pathol; 2019 Jan; 29(1):53-62. PubMed ID: 29679497
[TBL] [Abstract][Full Text] [Related]
7. Aggressive variant of a papillary glioneuronal tumor. Report of 2 cases.
Javahery RJ; Davidson L; Fangusaro J; Finlay JL; Gonzalez-Gomez I; McComb JG
J Neurosurg Pediatr; 2009 Jan; 3(1):46-52. PubMed ID: 19119904
[TBL] [Abstract][Full Text] [Related]
8. Genetic alterations in a papillary glioneuronal tumor.
Faria C; Miguéns J; Antunes JL; Barroso C; Pimentel J; Martins Mdo C; Moura-Nunes V; Roque L
J Neurosurg Pediatr; 2008 Jan; 1(1):99-102. PubMed ID: 18352813
[TBL] [Abstract][Full Text] [Related]
9. C11orf95-MKL2 is the resulting fusion oncogene of t(11;16)(q13;p13) in chondroid lipoma.
Huang D; Sumegi J; Dal Cin P; Reith JD; Yasuda T; Nelson M; Muirhead D; Bridge JA
Genes Chromosomes Cancer; 2010 Sep; 49(9):810-8. PubMed ID: 20607705
[TBL] [Abstract][Full Text] [Related]
10. Papillary glioneuronal tumor.
Gelpi E; Preusser M; Czech T; Slavc I; Prayer D; Budka H
Neuropathology; 2007 Oct; 27(5):468-73. PubMed ID: 18018482
[TBL] [Abstract][Full Text] [Related]
11. Papillary glioneuronal tumor. Case report and literature review.
Celli P; Caroli E; Giangaspero F; Ferrante L
J Neurooncol; 2006 Nov; 80(2):185-9. PubMed ID: 16703452
[TBL] [Abstract][Full Text] [Related]
12. Pigment-Synthesizing Melanocytic Neoplasm With Protein Kinase C Alpha (PRKCA) Fusion.
Bahrami A; Lee S; Wu G; Kerstetter J; Rahvar M; Li X; Easton J; Zhang J; Barnhill RL
JAMA Dermatol; 2016 Mar; 152(3):318-22. PubMed ID: 26676968
[TBL] [Abstract][Full Text] [Related]
13. Papillary glioneuronal tumor--contribution to a new tumor entity and literature review.
Guo SP; Zhang F; Li QL; Li Q; Wang WL; Li FF
Clin Neuropathol; 2008; 27(2):72-7. PubMed ID: 18402385
[TBL] [Abstract][Full Text] [Related]
14. Papillary glioneuronal tumor with minigemistocytic components and increased proliferative activity.
Ishizawa T; Komori T; Shibahara J; Ishizawa K; Adachi J; Nishikawa R; Matsutani M; Hirose T
Hum Pathol; 2006 May; 37(5):627-30. PubMed ID: 16647962
[TBL] [Abstract][Full Text] [Related]
15. Papillary glioneuronal tumor of the frontal lobe.
Mahajan H; Varikatt W; Dexter M; Boadle R; Ng T
J Clin Neurosci; 2010 Apr; 17(4):534-6. PubMed ID: 20156688
[TBL] [Abstract][Full Text] [Related]
16. Papillary glioneuronal tumors: Distinctive cytological characteristics and cyto-histologic correlation.
Puzyrenko A; Cochran E; Giorgadze T; Nomani L
Ann Diagn Pathol; 2021 Aug; 53():151757. PubMed ID: 33991783
[TBL] [Abstract][Full Text] [Related]
17. Detection of t(11;22)(q24;q12) translocation and EWS-FLI-1 fusion transcript in a case of solid pseudopapillary tumor of the pancreas.
Maitra A; Weinberg AG; Schneider N; Patterson K
Pediatr Dev Pathol; 2000; 3(6):603-5. PubMed ID: 11000339
[No Abstract] [Full Text] [Related]
18. Olig2-positive cells in glioneuronal tumors show both glial and neuronal characters: the implication of a common progenitor cell?
Matsumura N; Yokoo H; Mao Y; Yin W; Nakazato Y
Neuropathology; 2013 Jun; 33(3):246-55. PubMed ID: 23025580
[TBL] [Abstract][Full Text] [Related]
19. The solute carrier 44A1 is a mitochondrial protein and mediates choline transport.
Michel V; Bakovic M
FASEB J; 2009 Aug; 23(8):2749-58. PubMed ID: 19357133
[TBL] [Abstract][Full Text] [Related]
20. Papillary glioneuronal tumor with a high proliferative component and minigemistocytes in a child.
Momota H; Fujii M; Tatematsu A; Shimoyama Y; Tsujiuchi T; Ohno M; Natsume A; Wakabayashi T
Neuropathology; 2014 Oct; 34(5):484-90. PubMed ID: 24738632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
